arrow
R

Rebecca Gardner

Seattle Children's Research Institute
H指数:31
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intracerebroventricular B7-H3-targeting chimeric antigen receptor T cells for non-pontine diffuse midline glioma and recurrent/refractory pediatric CNS tumors: A phase 1 trial

脑室内B7-H3靶向嵌合抗原受体T细胞治疗非脑桥弥漫性中线胶质瘤和复发/难治性儿童中枢神经系统肿瘤:一项1期临床试验

2026-07-250
PRE
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response

B细胞系靶向car-t细胞治疗对体液免疫和疫苗诱导的抗体反应的影响

2026-04-070
OAAI
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort review

CD19 CAR T细胞在复发/难治性髓外B-ALL中的疗效:一项多中心、回顾性队列研究

2026-02-190
OAAI
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statement

关于CD19-CAR T细胞疗法后B细胞恢复定义的标准化:一项国际共识声明

2025-11-120
OAAI
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

国际共识指南:关于AML CAR T细胞临床研究的实施与报告

2025-08-210
OAAI
Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trial

Gust J,Cole BL,Ronsley R,Wilson AL,Seidel K,Wendler J,等. 局部区域灌注EGFR806-CAR T细胞治疗复发或难治性儿童中枢神经系统肿瘤:已完成brainChild02期1临床试验的结果. Neuro Oncol. (2025). doi: 10.1093/neuonc/noaf064

2025-06-016
PRE
Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia

外周血计数低和升高的促炎细胞因子预示急性淋巴细胞白血病中CD19嵌合抗原受体T细胞反应不良

2025-05-200
OAAI
Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL

PLAT-02和PLAT-03的研究结果:评估CD19 CAR T细胞疗法及CD19表达T-APC支持在儿童B-ALL中的应用

Blood
IF23.1
2025-04-170
PRE
Development of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia

ALL-Hematotox的开发:预测B细胞急性淋巴细胞白血病中CAR T细胞疗法后的血液毒性

BLOOD
IF23.1
2024-11-191
OA
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04
2024-11-110
PRE
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified fi ed Cell Therapies
2024-08-012
PRE
INTRAVENTRICULAR B7-H3 CAR T CELLS FOR DIFFUSE INTRINSIC PONTINE GLIOMA: SAFETY AND EFFICACY REPORT FROM THE COMPLETED PHASE 1 TRIAL BRAINCHILD-03

脑室内B7-H3 CAR T细胞治疗弥漫性内在性脑桥胶质瘤: 已完成的1期试验BRAINCHILD-03的安全性和有效性报告

2024-06-181
OAAI
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04
2024-06-181
OAAI
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing

药物调节的CD33-targeted CAR T细胞使用临床优化的雷帕霉素剂量控制AML

2024-03-198
OAAI
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure

嵌合抗原受体T细胞作为嵌合抗原受体后T细胞衰竭的挽救疗法

2023-09-014
OAAI